الرئيسية › سرطان الثدي › كارولاينا الشمالية › Durham
التجارب السريرية لـ سرطان الثدي في Durham، NC
64 دراسات لـ سرطان الثدي تبحث عن مشاركين في مواقع داخل وحول Durham (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
The Vanguard Study: Testing a New Way to Screen for Cancer
جارٍ التسجيلمرحباً بالمتطوعين الأصحاء
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · على بُعد 10 ميل
A Study of PHST001 in Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
جارٍ التسجيلالمرحلة 1/2
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
جارٍ التسجيلالمرحلة 3
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
جارٍ التسجيلالمرحلة 2مرحباً بالمتطوعين الأصحاء
- University of North Carolina, Chapel Hill · على بُعد 10 ميل
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
جارٍ التسجيلالمرحلة 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · على بُعد 10 ميل
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
جارٍ التسجيلدراسة رصدية
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- University of North Carolina, Chapel Hill · على بُعد 10 ميل
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
جارٍ التسجيلالمرحلة 2
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
جارٍ التسجيلالمرحلة 3
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
جارٍ التسجيلالمرحلة 1
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
جارٍ التسجيلالمرحلة 3
- University of North Carolina Medical Center, Chapel Hill · على بُعد 10 ميل
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
جارٍ التسجيلالمرحلة 2
- University of North Carolina Medical Center, Chapel Hill · على بُعد 10 ميل
Identifying Patterns in the Breath of Individuals With Breast Cancer
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
جارٍ التسجيلالمرحلة 2
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · على بُعد 10 ميل
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
جارٍ التسجيلالمرحلة 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · على بُعد 10 ميل
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
جارٍ التسجيلالمرحلة 3
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
جارٍ التسجيلدراسة رصدية
- University of North Carolina at Chapel Hill, Chapel Hill · على بُعد 10 ميل
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
جارٍ التسجيلالمرحلة 1/2
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
جارٍ التسجيلالمرحلة 1
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
جارٍ التسجيلالمرحلة 1/2
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
جارٍ التسجيلالمرحلة 3
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
جارٍ التسجيلالمرحلة 2
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
جارٍ التسجيلالمرحلة 2
- University of North Carolina, Chapel Hill · على بُعد 10 ميل
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
جارٍ التسجيلالمرحلة 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · على بُعد 10 ميل
- University of North Carolina-Hillsborough Campus, Hillsborough · على بُعد 13 ميل
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
جارٍ التسجيلمرحباً بالمتطوعين الأصحاء
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · على بُعد 10 ميل
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
جارٍ التسجيلالمرحلة 2
- University of North Carolina, Chapel Hill · على بُعد 10 ميل
Optimizing Surgical Decisions in Young Adults With Breast Cancer
جارٍ التسجيل
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
جارٍ التسجيلدراسة رصدية
- University of North Carolina, Chapel Hill · على بُعد 10 ميل
Weight Management After Cancer for Survivors in Rural Communities
جارٍ التسجيل
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
جارٍ التسجيل
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
جارٍ التسجيلالمرحلة 2/3
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
جارٍ التسجيل
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
جارٍ التسجيلالمرحلة 2
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
جارٍ التسجيل
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
جارٍ التسجيلالمرحلة 1
- University of North Carolina, Chapel Hill · على بُعد 10 ميل
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
جارٍ التسجيل
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · على بُعد 10 ميل
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
جارٍ التسجيل
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
جارٍ التسجيلدراسة رصدية
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · على بُعد 10 ميل
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
جارٍ التسجيلالمرحلة 3
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
جارٍ التسجيلالمرحلة 1
- University of North Carolina, Chapel Hill · على بُعد 10 ميل
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
جارٍ التسجيلالمرحلة 2مرحباً بالمتطوعين الأصحاء
- The University of North Carolina, Chapel Hill · على بُعد 10 ميل
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
جارٍ التسجيلدراسة رصدية
- University of North Carolina at Chapel Hill, Chapel Hill · على بُعد 10 ميل
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
جارٍ التسجيلالمرحلة 2
- University of North Carolina, Chapel Hill · على بُعد 10 ميل
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
جارٍ التسجيل
- University of North Carolina, Chapel Hill · على بُعد 10 ميل
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
جارٍ التسجيلالمرحلة 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · على بُعد 10 ميل
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
جارٍ التسجيلالمرحلة 2
- The University of North Carolina at Chapel Hill, Chapel Hill · على بُعد 10 ميل
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
جارٍ التسجيلالمرحلة 2
- University of North Carolina, Chapel Hill · على بُعد 10 ميل
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
جارٍ التسجيلالمرحلة 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · على بُعد 10 ميل
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
جارٍ التسجيل
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
جارٍ التسجيلالمرحلة 1/2
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
جارٍ التسجيلدراسة رصدية
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · على بُعد 10 ميل
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
جارٍ التسجيلالمرحلة 2
- University of North Carolina, Chapel Hill · على بُعد 10 ميل
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
جارٍ التسجيلالمرحلة 1
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
جارٍ التسجيل
- UNC Cancer Hospital, Chapel Hill · على بُعد 10 ميل
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
جارٍ التسجيل
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · على بُعد 10 ميل
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
جارٍ التسجيل
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
جارٍ التسجيل
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · على بُعد 10 ميل
BREAST Choice Decision Tool R21 - AIM2
جارٍ التسجيلمرحباً بالمتطوعين الأصحاء
- The University of North Carolina, Chapel Hill · على بُعد 10 ميل
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
جارٍ التسجيل
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
جارٍ التسجيلدراسة رصدية
- Massive Bio SYNERGY-AI site, Chapel Hill · على بُعد 10 ميل
UNC Pleural Fluid Registry
جارٍ التسجيلدراسة رصدية
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · على بُعد 10 ميل
تجارب سرطان الثدي في مدن أخرى
- New York City, NY136 دراسات
- Houston, TX126 دراسات
- Boston, MA112 دراسات
- Nashville, TN81 دراسات
- Los Angeles, CA73 دراسات
- Edison, NJ68 دراسات
- St. Louis, MO64 دراسات
- Queens, NY64 دراسات
- Chicago, IL59 دراسات
- Philadelphia, PA56 دراسات
- Dallas, TX55 دراسات
- Arlington, VA47 دراسات
دراسات أخرى في Durham
- السرطان (جميع الأنواع)58 دراسات
- سرطان الرئة غير صغير الخلايا39 دراسات
- الورم النقوي المتعدد37 دراسات
- ابيضاض الدم النقوي الحاد33 دراسات
- السرطان النقيلي33 دراسات
- سرطان البروستاتا32 دراسات
- سرطان الرئة32 دراسات
- سرطان القولون والمستقيم28 دراسات
- سرطان المبيض27 دراسات
- ابيضاض الدم اللمفاوي المزمن27 دراسات
- قصور القلب26 دراسات
- سرطان البنكرياس24 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 06/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.